(Q44573557)

4 December 2017

title

Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis (English)

1 reference

4 December 2017

0 references

1 reference

Jorge H Serna

1

1 reference

4 December 2017

Audrey Wanger

series ordinal

2

1 reference

4 December 2017

Akinsansoye K Dosekun

series ordinal

3

1 reference

4 December 2017

publication date

1 September 2003

1 reference

American Journal of Kidney Diseases

4 December 2017

published in

1 reference

4 December 2017

volume

42

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

E14-7

1 reference

Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Fungal peritonitis during continuous ambulatory peritoneal dialysis: a report of 17 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Mucormycosis of the graft in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Mucormycosis in transplant recipients: possible case-case transmission and potentiation by cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Gastrointestinal mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Fungal peritonitis in continuous ambulatory peritoneal dialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Liver and brain mucormycosis in a diabetic patient type II successfully treated with liposomial amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Abdominal wall mucormycosis successfully treated with amphotericin and itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Mucormycosis of the gastrointestinal tract in children: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Treatment of deep mycoses with liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900797-2

7 January 2021

10.1016/S0272-6386(03)00797-2

Identifiers

DOI

1 reference

4 December 2017

1 reference